LH insider Form 144: 5,745-share sale notice via Fidelity
Rhea-AI Filing Summary
Laboratory Corporation of America Holdings (LH) reported a Form 144 notice of a proposed sale of 5,745 common shares, with an aggregate market value of $1,509,498.75. The filing lists Fidelity Brokerage Services LLC as broker, an approximate sale date of 11/11/2025, and the NYSE as the exchange. Shares outstanding were 82,900,000.
The shares to be sold were acquired through restricted stock vesting on 02/02/2024 (1,911 shares), 02/07/2024 (2,101 shares), and 02/11/2024 (1,733 shares). The filing also shows a recent transaction by a named seller: Adam H. Schechter sold 5,643 shares on 08/11/2025 for $1,505,439.54 in gross proceeds.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 notice for a modest insider share sale.
This Form 144 lists a proposed sale of 5,745 LH common shares with an aggregate market value of $1,509,498.75, routed through Fidelity and intended for the NYSE. The shares earmarked for sale were acquired via restricted stock vesting on three February 2024 dates, indicating equity compensation being monetized.
Form 144 is a notice requirement for affiliates under Rule 144 and does not itself execute the sale. The excerpt also notes a prior sale on 08/11/2025 of 5,643 shares for $1,505,439.54. Actual trading activity will depend on market conditions and affiliate constraints under Rule 144.
This appears administrative and typical for equity compensation. No use-of-proceeds or company cash flow is involved; transactions occur for the selling holder’s account.